Compare Coursera Inc (COUR) vs Definium Therapeutics Inc. Common Shares (DFTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Coursera Inc vs Definium Therapeutics Inc. Common Shares — how do they compare? Coursera Inc trades at $5.28 (market cap $1.35B), while Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 3.5× Coursera Inc's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Coursera Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Coursera Inc for 47 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| COUR | DFTX | |
|---|---|---|
Market Cap | $1.35B | $4.71B |
Volume | 5,442,629 | 1,966,636 |
Sector | Consumer Staples | Health |
52-Week High | $10.73 | $48.45 |
52-Week Low | $4.64 | $10.68 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | $606.18M | $3.67B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coursera (COUR) trades at $5.27, up 2.93% with a bearish technical signal despite recent earnings beats. Revenue growth is solid (2025: $758M, 2026: $885M projected) but profitability remains negative with a -15.39% net margin. Analyst consensus is bullish with a $7.40 price target (52.94% buy ratings), while institutional activity shows mixed positioning amid Project Helix AI platform developments.
The stock offers upside potential from AI-driven growth and margin improvements, but faces execution risks on profitability and integration costs. High RSI near 82 suggests overbought conditions, while persistent net losses and competitive pressures in edtech warrant caution for near-term volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Coursera Inc
Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →
